In contrast, CCL2 values did not change according to the prognosis of CRC patients and the acute phase protein Pentraxin-3 had only a tendency to increase (P = 0.11) among those patients who experienced postsurgical disease recurrence (Fig 1). Here, PTX3 is linked to colorectal carcinoma.